Authors
Loading...
Molecular review uncovers flexible phosphoproteome dynamics in CK2-null cancer models, indicating unexpected therapeutic druggability despite constitutive pleiotropic activity.
Franchin et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: